Oliver Kiddie – Managing Director – Legend Mining (ASX:LEG) is an Australian exploration company listed on the Australian Securities Exchange (ASX:LEG). Legend’s mission is to make value-adding mineral discoveries and utilise all available asset bases to maximise stakeholder benefit.
Copyright 2024 – Finance News Network
Source: Finance News Network
16 Nov 2023 - Linius Technologies Limited (ASX:LNU) CEO and Executive Director James Brennan discusses the company's quarterly performance and its technology for rendering video files as flexible as other forms of data.
Read More11 Sep 2019 - BluGlass Limited (ASX:BLG) Managing Director Giles Bourne discusses partnering with LED lighting developer Bridgelux, enabling smaller and cheaper LEDs, and what the future holds with BLG’s new facility.
Read More12 May 2021 - Galan Lithium (ASX:GLN) Managing Director Juan Pablo Vargas de la Vega provides an update on they company's key Hombre Muerto lithium brine project in the Catamarca province of Argentina.
Read More16 Dec 2019 - Openpay Group (ASX:OPY) CEO & MD, Michael Eidel talks about its business model, size of the opportunity and how it differentiates itself from other buy now pay later (BNPL) providers.
Read More06 Aug 2024 - Alderan Resources Limited (ASX:AD8) Managing Director Scott Caithness discusses the company's exploration targets and progress.
Read More17 Mar 2025 - LAG-3 and the Role of Immune Checkpoints in Cancer Treatment
Read More21 Mar 2023 - Aspen Group Limited (ASX:APZ) Executive Director and Joint CEO John Carter provides an introduction to the company, discussing target market, the rising interest rate environment, portfolio mix and development pipeline.
Read More05 Nov 2024 - Paul Sanger interviews Anthony Noble, CEO of The Calmer Co (ASX:CCO), a leader in sustainable kava production. The Calmer Co aims to become the world's dominant kava company by promoting kava's calming and health benefits while improving the livelihoods of farmers in Fiji through fair pricing and a transparent supply chain.
Read More29 Mar 2021 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt talks about the Bristol Myers Squibb trial evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo (nivolumab) in patients with previously untreated metastatic or unresectable melanoma, meeting its primary endpoint of progression-free survival and what it means for Immutep.
Read More19 Aug 2022 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director Garry Crole discusses FY22 financial highlights, future margin growth, acquisition strategy and dividend policy.
Read More
